Related Experiment Video
Updated: May 12, 2025
A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
Stage-specific dynamics of macular pigment optical density as a prognostic biomarker in epiretinal membrane surgery
Alberto Quarta1, Lisa Toto2, Matteo Gironi3
1Department of Neurosciences, Imaging and Clinical Sciences, University 'G d'Annunzio' Chieti-Pescara, Chieti, Italy alberto.quarta.96@gmail.com.
Purpose:
To explore macular pigment optical density (MPOD) dynamics in stage 2 and stage 3 epiretinal membranes (ERMs) and to evaluate its pre and postoperative modifications. Furthermore, the study assessed the potential of MPOD as a prognostic biomarker in ERM management.
Methods:
A cohort of stage 2 (n=21) and 3 (n=20) ERM patients, matched for age and gender, underwent clinical evaluation at baseline and postoperative follow-up. Correlations between MPOD and optical coherence tomography parameters were analysed within each group.
Results:
Postoperative MPOD levels significantly differed between stage 2 and 3 ERM patients (p=0.027). Changes in MPOD over time (ΔMPOD) were significantly greater in stage 3 compared with stage 2 participants (p=0.018). In stage 2, ΔMPOD correlated with changes in best-corrected visual acuity (ΔBCVA) (r=0.398, p=0.074) and demonstrated a strong correlation with changes in outer nuclear layer thickness (r=0.672, p<0.001). In stage 3, ΔMPOD exhibited a significant negative correlation with changes in central foveal thickness (r=-0.547, p=0.013) and a positive correlation with ΔBCVA (r=0.510, p=0.022).
Conclusions:
MPOD exhibited stage-specific dynamics and significant postoperative changes. Correlation between ΔMPOD and ΔBCVA in both stages highlights its potential role as a prognostic functional biomarker.
Insights
Macular pigment optical density (MPOD) shows distinct changes after surgery for epiretinal membranes (ERMs). MPOD dynamics correlate with visual acuity, suggesting its use as a prognostic biomarker in ERM management.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Biomarker Research
Background:
- Epiretinal membranes (ERMs) affect vision by distorting the macula.
- Understanding the functional impact of ERMs and their surgical outcomes is crucial for patient management.
Purpose of the Study:
- To investigate macular pigment optical density (MPOD) changes in stage 2 and 3 ERMs before and after surgery.
- To assess MPOD's potential as a prognostic biomarker for ERM management.
Main Methods:
- A cohort of 41 patients with stage 2 (n=21) and stage 3 (n=20) ERMs were evaluated.
- MPOD and optical coherence tomography (OCT) parameters were analyzed preoperatively and postoperatively.
- Correlations between MPOD and OCT parameters were assessed within each ERM stage.
Main Results:
- Postoperative MPOD levels differed significantly between stage 2 and stage 3 ERMs (p=0.027).
- Changes in MPOD (ΔMPOD) were significantly greater in stage 3 than stage 2 ERMs (p=0.018).
- In stage 2, ΔMPOD correlated with outer nuclear layer thickness changes (r=0.672, p<0.001). In stage 3, ΔMPOD correlated with central foveal thickness (r=-0.547, p=0.013) and visual acuity changes (r=0.510, p=0.022).
Conclusions:
- MPOD exhibits stage-specific dynamics and significant postoperative modifications in ERM patients.
- The correlation between ΔMPOD and changes in best-corrected visual acuity (ΔBCVA) supports MPOD's role as a functional prognostic biomarker.
